CNS Involvement in AML at Diagnosis Is Rare and Does Not Affect Response or Survival
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials
Blood Adv 2021 Nov 23;5(22)4560-4568, C Ganzel, JW Lee, HF Fernandez, EM Paietta, SM Luger, HM Lazarus, LD Cripe, D Douer, PH Wiernik, JM Rowe, MS Tallman, MR LitzowFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.